A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties
- PMID: 19307114
- DOI: 10.1016/j.bmcl.2009.02.126
A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties
Abstract
We have been exploring the potential of 5-HT(2B) antagonists as a therapy for chronic heart failure. To assess the potential of this therapeutic approach, we sought compounds possessing the following attributes: (a) potent and selective antagonism of the 5-HT(2B) receptor, (b) low impact of serum proteins on potency, and (c) desirable pharmacokinetic properties. This Letter describes our investigation of a biphenyl benzimidazole class of compounds that resulted in 5-HT(2B) antagonists possessing the above attributes. Improving potency in a human serum albumin shift assay proved to be the most significant SAR discovery.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases
Miscellaneous
